Roivant Sciences Ltd. Common Shares vs XP Inc. Class A Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while XP Inc. Class A Common Stock trades at $30.27 (market cap $14.99B). The key difference: Roivant Sciences Ltd. Common Shares is the larger of the two by market cap, and XP Inc. Class A Common Stock pays a 0.68% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and XP Inc. Class A Common Stock for 0 Days on average.
| ROIV | XP | |
|---|---|---|
Market Cap | $25.09B | $14.99B |
Volume | 5,738,571 | 14,273,752 |
Sector | Health | Financials |
52-Week High | $41.81 | $30.21 |
52-Week Low | $16.04 | $14.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.36B | $24.70B |
Dividend Yield | — | 0.68% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →